| The YLQPRTFLL peptide corresponds to the S269Ð277 epitope of the SARS-CoV-2 spike protein. Presented by HLA-A*02:01, it is recognized by CD8+ T cells and is a target for immune responses in COVID-19 patients. This epitope is significant in studies of T cell immunity, vaccine design, and understanding the adaptive immune response to SARS-CoV-2. |